Consistent with these studies, we observed that activate mutant Beclin-1 Becn1F121A or treatment with TB-peptide provided a significant reduction in infection, locally in the lung and systemically in blood and in distant organs, in response to infection by K. pneumoniae (Figures 2 and 4). This evidence concerns the gene BECN1 and tuberculosis.